Multiple Assemblies exist for SMTL entry 8bdm
VCB in complex with compound 26; X-RAY DIFFRACTION 2.02 Å

SMTL ID
8bdm.1
Ligands
(2~{S},4~{R})-~{N}-[[2-(2-methoxyethoxy)-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2~{R})-3-methyl-2-(3-methyl-1,2-oxazol-5-yl)butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide
Polypeptides
Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor
Oligo-state
hetero-1-1-1-mer
SMTL ID
8bdm.2
Ligands
(2~{S},4~{R})-~{N}-[[2-(2-methoxyethoxy)-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2~{R})-3-methyl-2-(3-methyl-1,2-oxazol-5-yl)butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide
Polypeptides
Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor
Oligo-state
hetero-1-1-1-mer
SMTL ID
8bdm.3
Ligands
(2~{S},4~{R})-~{N}-[[2-(2-methoxyethoxy)-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2~{R})-3-methyl-2-(3-methyl-1,2-oxazol-5-yl)butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide
Polypeptides
Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor
Oligo-state
hetero-1-1-1-mer
SMTL ID
8bdm.4
Ligands
(2~{S},4~{R})-~{N}-[[2-(2-methoxyethoxy)-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2~{R})-3-methyl-2-(3-methyl-1,2-oxazol-5-yl)butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide
Polypeptides
Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor
Oligo-state
hetero-1-1-1-mer